223 related articles for article (PubMed ID: 16427035)
1. Two-dimensional 13C-1H heteronuclear correlation NMR spectroscopic studies for the inclusion complex of cyclomaltoheptaose (beta-cyclodextrin) with a new Helicobacter pylori eradicating agent (TG44) in the amorphous state.
Anzai K; Kono H; Mizoguchi J; Yanagi T; Hirayama F; Arima H; Uekama K
Carbohydr Res; 2006 Mar; 341(4):499-506. PubMed ID: 16427035
[TBL] [Abstract][Full Text] [Related]
2. Improvement of dissolution properties of a new Helicobacter pylori eradicating agent (TG44) by inclusion complexation with beta-cyclodextrin.
Anzai K; Mizoguchi J; Yanagi T; Hirayama F; Arima H; Uekama K
Chem Pharm Bull (Tokyo); 2007 Oct; 55(10):1466-70. PubMed ID: 17917290
[TBL] [Abstract][Full Text] [Related]
3. Theoretical study on interactions of β-cyclodextrin with Helicobacter pylori eradicating agent (TG44).
Jin X; Wang X; Ren C; Miao Y; Yi L
J Mol Model; 2011 Apr; 17(4):913-20. PubMed ID: 20607331
[TBL] [Abstract][Full Text] [Related]
4. Cyclodextrins as carriers for kavalactones in aqueous media: spectroscopic characterization of (S)-7,8-dihydrokavain and beta-cyclodextrin inclusion complex.
Pescitelli G; Bilia AR; Bergonzi MC; Vincieri FF; Di Bari L
J Pharm Biomed Anal; 2010 Aug; 52(4):479-83. PubMed ID: 20185265
[TBL] [Abstract][Full Text] [Related]
5. Solid-state 13C nuclear magnetic resonance spectroscopic study on amorphous solid complexes of tolbutamide with 2-hydroxypropyl-alpha- and -beta-cyclodextrins.
Kimura K; Hirayama F; Arima H; Uekama K
Pharm Res; 1999 Nov; 16(11):1729-34. PubMed ID: 10571279
[TBL] [Abstract][Full Text] [Related]
6. Inclusion complexes of bisphenol A with cyclomaltoheptaose (beta-cyclodextrin): solubilization and structure.
Yang ZX; Chen Y; Liu Y
Carbohydr Res; 2008 Sep; 343(14):2439-42. PubMed ID: 18653172
[TBL] [Abstract][Full Text] [Related]
7. Sildenafil/cyclodextrin complexation: stability constants, thermodynamics, and guest-host interactions probed by 1H NMR and molecular modeling studies.
Al Omari MM; Zughul MB; Davies JE; Badwan AA
J Pharm Biomed Anal; 2006 Jun; 41(3):857-65. PubMed ID: 16527440
[TBL] [Abstract][Full Text] [Related]
8. Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization.
Al Omari MM; Daraghmeh NH; El-Barghouthi MI; Zughul MB; Chowdhry BZ; Leharne SA; Badwan AA
J Pharm Biomed Anal; 2009 Oct; 50(3):449-58. PubMed ID: 19545961
[TBL] [Abstract][Full Text] [Related]
9. Interaction between beta-cyclodextrin and 1,10-phenanthroline: uncommon 2:3 inclusion complex in the solid state.
Liu Y; Chen GS; Zhang HY; Song HB; Ding F
Carbohydr Res; 2004 Jun; 339(9):1649-54. PubMed ID: 15183740
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the inclusion complex of the antibacterial agent triclosan with cyclomaltoheptaose and NMR study of its molecular encapsulation in positively and negatively charged cyclomaltoheptaose derivatives.
Paulidou A; Maffeo D; Yannakopoulou K; Mavridis IM
Carbohydr Res; 2008 Oct; 343(15):2634-40. PubMed ID: 18684438
[TBL] [Abstract][Full Text] [Related]
11. Two-dimensional magic angle spinning NMR investigation of naturally occurring chitins: precise 1H and 13C resonance assignment of alpha- and beta-chitin.
Kono H
Biopolymers; 2004 Oct; 75(3):255-63. PubMed ID: 15378483
[TBL] [Abstract][Full Text] [Related]
12. UV-vis and FTIR-ATR spectroscopic techniques to study the inclusion complexes of genistein with beta-cyclodextrins.
Crupi V; Ficarra R; Guardo M; Majolino D; Stancanelli R; Venuti V
J Pharm Biomed Anal; 2007 May; 44(1):110-7. PubMed ID: 17379467
[TBL] [Abstract][Full Text] [Related]
13. Physico-chemical characterization of disoxaril-dimethyl-beta-cyclodextrin inclusion complex and in vitro permeation studies.
Ventura CA; Giannone I; Musumeci T; Pignatello R; Ragni L; Landolfi C; Milanese C; Paolino D; Puglisi G
Eur J Med Chem; 2006 Feb; 41(2):233-40. PubMed ID: 16387393
[TBL] [Abstract][Full Text] [Related]
14. Multi-dimensional 1H-13C HETCOR and FSLG-HETCOR NMR study of sphingomyelin bilayers containing cholesterol in the gel and liquid crystalline states.
Holland GP; Alam TM
J Magn Reson; 2006 Aug; 181(2):316-26. PubMed ID: 16798032
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
Jadhav GS; Vavia PR
Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
[TBL] [Abstract][Full Text] [Related]
16. 1H NMR spectroscopic study of complexation of citalopram with beta-cyclodextrin in aqueous solution.
Mashhood Ali S; Maheshwari A; Inder Fozdar B
Magn Reson Chem; 2007 Mar; 45(3):253-6. PubMed ID: 17290386
[TBL] [Abstract][Full Text] [Related]
17. Raman and solid state 13C-NMR investigation of the structure of the 1 : 1 amorphous piroxicam : beta-cyclodextrin inclusion compound.
Redenti E; Zanol M; Ventura P; Fronza G; Comotti A; Taddei P; Bertoluzza A
Biospectroscopy; 1999; 5(4):243-51. PubMed ID: 10478955
[TBL] [Abstract][Full Text] [Related]
18. Complexation study of midazolam hydrochloride with beta-cyclodextrin: NMR spectroscopic study in solution.
Ali SM; Upadhyay SK
Magn Reson Chem; 2008 Jul; 46(7):676-9. PubMed ID: 18381674
[TBL] [Abstract][Full Text] [Related]
19. Preparation of celecoxib-dimethyl-beta-cyclodextrin inclusion complex: characterization and in vitro permeation study.
Ventura CA; Giannone I; Paolino D; Pistarà V; Corsaro A; Puglisi G
Eur J Med Chem; 2005 Jul; 40(7):624-31. PubMed ID: 15935897
[TBL] [Abstract][Full Text] [Related]
20. Spectroscopic studies of inclusion complex of beta-cyclodextrin and benzidine diammonium dipicrate.
Hamdi H; Abderrahim R; Meganem F
Spectrochim Acta A Mol Biomol Spectrosc; 2010 Jan; 75(1):32-6. PubMed ID: 19879800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
